Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
about
HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.Autophagy protein LC3 regulates the fibrosis of hypertrophic scar by controlling Bcl-xL in dermal fibroblasts.Overexpression of miR-101 promotes TRAIL-induced mitochondrial apoptosis in papillary thyroid carcinoma by targeting c-met and MCL-1.Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression.Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells.Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells.Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin.
P2860
Q42335712-E2B0C096-FE64-405D-BA93-186022725D6CQ47137354-63660B67-8B5C-4B24-B218-D1C56682E28EQ47220576-36FC20BA-0A2A-4757-A9D0-D0475F0B2742Q49882954-26EC93AF-3B6C-483F-A602-25243E734091Q51760860-557AC9A8-333D-47DB-90C1-ABCBFBA4BBFFQ52579567-6F248482-D88A-4134-A733-A13EA239E9ADQ52728203-154AB6B9-1A0E-49D5-8442-8FBA5E03938BQ55073638-6D87CAEF-C346-44E5-9BA0-B98C7DABF4BD
P2860
Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bcl-xL inhibition by molecular ...... creatic cancer cells to TRAIL.
@ast
Bcl-xL inhibition by molecular ...... creatic cancer cells to TRAIL.
@en
type
label
Bcl-xL inhibition by molecular ...... creatic cancer cells to TRAIL.
@ast
Bcl-xL inhibition by molecular ...... creatic cancer cells to TRAIL.
@en
prefLabel
Bcl-xL inhibition by molecular ...... creatic cancer cells to TRAIL.
@ast
Bcl-xL inhibition by molecular ...... creatic cancer cells to TRAIL.
@en
P2093
P2860
P356
P1433
P1476
Bcl-xL inhibition by molecular ...... creatic cancer cells to TRAIL.
@en
P2093
Mamoru Harada
Nanae Harashima
Yoshitsugu Tajima
P2860
P304
41902-41915
P356
10.18632/ONCOTARGET.5881
P407
P577
2015-10-19T00:00:00Z